Your search results

LIAISON^® BRAHMS PCT^® II Gen is a CLIA assay for the quantitative determination of procalcitonin in human serum and plasma specimens. The assay is intended for use, in conjunction with other laboratory findings and clinical assessments, to aid in the risk analysis for critically ill patients regarding the progression of relevant bacterial infections.

The first high-quality quantitative CLIA assay that assesses disease severity in patients with a suspected infection by detecting Mid-regional pro-adrenomedullin (MR-proADM^TM) via a single test. It is ideal for patients with suspected acute infections at ED and ICU.

LIAISON^® BRAHMS PCT^® II Gen is a CLIA assay for the quantitative determination of procalcitonin in human serum and plasma specimens. The assay is intended for use, in conjunction with other laboratory findings and clinical assessments, to aid in the risk analysis for critically ill patients regarding the progression of relevant bacterial infections.

The first high-throughput, fully automated CLIA assay to quickly differentiate between bacterial and viral infections in a single procedure. Combining host-immune protein measurements it overcomes the diagnostic difficulties of traditional testing methods, making LIAISON^® MeMed BV^® ideal for patients with suspected acute infections.

LIAISON^® QuantiFERON TB-Gold Plus is an IGRA based-test that drastically improves tuberculosis testing compared to traditional tests.

The first complete solution with optimal diagnostic performance for Bordetella pertussis diagnosis 

• LIAISON^® Bordetella pertussis Toxin IgA
• LIAISON^® Bordetella pertussis Toxin IgG

Differential serological diagnosis of Mycoplasma Pneumoniae: a crucial step for effective patient management.

The first high-throughput, fully automated CLIA assay to quickly differentiate between bacterial and viral infections in a single procedure. Combining host-immune protein measurements it overcomes the diagnostic difficulties of traditional testing methods, making LIAISON^® MeMed BV^® ideal for patients with suspected acute infections.

LIAISON^® QuantiFERON TB-Gold Plus is an IGRA based-test that drastically improves tuberculosis testing compared to traditional tests.

The first complete solution with optimal diagnostic performance for Bordetella pertussis diagnosis 

• LIAISON^® Bordetella pertussis Toxin IgA
• LIAISON^® Bordetella pertussis Toxin IgG

Differential serological diagnosis of Mycoplasma Pneumoniae: a crucial step for effective patient management.

The first high-quality quantitative CLIA assay that assesses disease severity in patients with a suspected infection by detecting Mid-regional pro-adrenomedullin (MR-proADM^TM) via a single test. It is ideal for patients with suspected acute infections at ED and ICU.

Differential serological diagnosis of Mycoplasma Pneumoniae: a crucial step for effective patient management.

LIAISON^® QuantiFERON TB-Gold Plus is an IGRA based-test that drastically improves tuberculosis testing compared to traditional tests.

The first high-throughput, fully automated CLIA assay to quickly differentiate between bacterial and viral infections in a single procedure. Combining host-immune protein measurements it overcomes the diagnostic difficulties of traditional testing methods, making LIAISON^® MeMed BV^® ideal for patients with suspected acute infections.

LIAISON^® QuantiFERON TB-Gold Plus is an IGRA based-test that drastically improves tuberculosis testing compared to traditional tests.

The first complete solution with optimal diagnostic performance for Bordetella pertussis diagnosis 

• LIAISON^® Bordetella pertussis Toxin IgA
• LIAISON^® Bordetella pertussis Toxin IgG